Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04691141
Status:
TERMINATED
Last Update Posted:
2024-04-17
First Post:
2020-12-23
Brief Title:
A Study to Evaluating the Pharmacokinetics Safety and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome MDS
Sponsor:
Shanghai Antengene Corporation Limited
Organization:
Antengene Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-23
First Submit QC Date:
December 29 2020
Study First Post Date:
2020-12-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-15
Last Update Post Date:
2024-04-17
Last Update Post Date Type:
ACTUAL